30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Talis Biomedical Corp (TLIS)

Track

Stock chart
Ticker: TLIS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Leonard Braden Michael
1 purchase — total 37,100 USD
Buy 6 Sep 2024
Value US$2,887,042.62 | Price 181.48 | Shares 38,825
Buy 5 Sep 2024
Value US$278,492.82 | Price 127.85 | Shares 60,683
Buy 3 Sep 2024
Value US$2,000.00 | Price 4.00 | Shares 500
Buy 30 Aug 2024
Value US$641.75 | Price 4.25 | Shares 151
Buy 28 Aug 2024
Value US$4,814.68 | Price 3.96 | Shares 1,215
Buy 26 Aug 2024
Value US$51,322.33 | Price 3.90 | Shares 13,167
Buy 18 Nov 2021
Value US$218,250.00 | Price 4.37 | Shares 50,000
Sale 13 Aug 2021
Value US$210,665.32 | Price 7.66 | Shares 27,502
Buy 17 May 2021
Value US$111,210.00 | Price 10.11 | Shares 11,000
Buy 14 May 2021
Value US$91,440.00 | Price 10.16 | Shares 9,000
Buy 17 Feb 2021
Value US$5,000,000.00 | Price 16.00 | Shares 312,500
Buy 17 Feb 2021
Value US$92,680,608.00 | Price 16.00 | Shares 5,792,538
Buy 17 Feb 2021
Value US$7,319,392.00 | Price 16.00 | Shares 457,462
Buy 17 Feb 2021
Value US$84,800.00 | Price 16.00 | Shares 5,300
Buy 17 Feb 2021
Value US$16,000.00 | Price 16.00 | Shares 1,000
Buy 17 Feb 2021
Value US$27,200.00 | Price 16.00 | Shares 1,700
Buy 17 Feb 2021
Value US$32,000.00 | Price 16.00 | Shares 2,000
Buy 17 Feb 2021
Value US$64,000.00 | Price 16.00 | Shares 4,000
Buy 17 Feb 2021
Value US$1,000,000.00 | Price 16.00 | Shares 62,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-09 2024-09-06 B Purchase
2.9
Leonard Braden Michael
Large shareholder
38,825 -1.1%
181.48
US$2,887,043 		38,825 -1.1% 181.48 US$2,887,043
2024-09-09 2024-09-05 B Purchase
2.9
Leonard Braden Michael
Large shareholder
60,683 +27.5%
127.85
US$278,493 		60,683 +27.5% 127.85 US$278,493
2024-09-05 2024-09-03 B Purchase
2.9
Leonard Braden Michael
Large shareholder
78,859 -30.0%
70.91
US$3,947,209 		78,859 -30.0% 70.91 US$3,947,209
2024-09-04 2024-08-30 B Purchase
2.9
Leonard Braden Michael
Large shareholder
151 +0.1%
4.25
US$642 		151 +0.1% 4.25 US$642
2024-08-28 2024-08-28 B Purchase
2.9
Leonard Braden Michael
Large shareholder
1,215 +0.6%
3.96
US$4,815 		1,215 +0.6% 3.96 US$4,815
2024-08-28 2024-08-26 B Purchase
2.9
Leonard Braden Michael
Large shareholder
13,167 +6.5%
3.90
US$51,322 		13,167 +6.5% 3.90 US$51,322
2021-11-19 2021-11-18 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
50,000 +0.7%
4.37
US$218,250 		50,000 +0.7% 4.37 US$218,250
2021-08-17 2021-08-13 S Sale
2.5
Ramakrishnan Ramesh

Former Officer
27,502 -41.6%
7.66
US$210,665 		27,502 -41.6% 7.66 US$210,665
2021-05-18 2021-05-17 B Purchase
2.6
Scott Randal W.
Non-Executive Director
11,000 +122.2%
10.11
US$111,210 		11,000 +122.2% 10.11 US$111,210
2021-05-18 2021-05-14 B Purchase
2.6
Scott Randal W.
Non-Executive Director
9,000 +inf%
10.16
US$91,440 		9,000 +inf% 10.16 US$91,440
2021-02-19 2021-02-17 B Purchase
2.6
Scott Randal W.
Non-Executive Director
312,500 +inf%
16.00
US$5,000,000 		312,500 +inf% 16.00 US$5,000,000
2021-02-19 2021-02-17 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
5,792,538 +478.5%
16.00
US$92,680,608 		5,792,538 +478.5% 16.00 US$92,680,608
2021-02-19 2021-02-17 B Purchase
Popovits Kimberly J
Non-Executive Director
5,300 +2.5%
16.00
US$84,800 		5,300 +2.5% 16.00 US$84,800
2021-02-19 2021-02-17 B Purchase
2.5
Ramakrishnan Ramesh

Sr. Vice President, R&D

Officer
1,000 +inf%
16.00
US$16,000 		1,000 +inf% 16.00 US$16,000
2021-02-19 2021-02-17 B Purchase
Moody John Roger Jr

Chief Financial Officer

Officer
1,700 +inf%
16.00
US$27,200 		1,700 +inf% 16.00 US$27,200
2021-02-19 2021-02-17 B Purchase
Flick Karen E.

Chief of Staff, Sr. VP, Legal

Officer
2,000 +inf%
16.00
US$32,000 		2,000 +inf% 16.00 US$32,000
2021-02-19 2021-02-17 B Purchase
Liu Douglas

Sr. Vice President, Operations

Officer
4,000 +inf%
16.00
US$64,000 		4,000 +inf% 16.00 US$64,000
2021-02-19 2021-02-17 B Purchase
3.9
BAKER BROS. ADVISORS LP
Non-Executive Director Large shareholder
457,462 +400.6%
16.00
US$7,319,392 		457,462 +400.6% 16.00 US$7,319,392
2021-02-19 2021-02-17 B Purchase
3.0
Posard Matthew L.
Non-Executive Director
62,500 +inf%
16.00
US$1,000,000 		62,500 +inf% 16.00 US$1,000,000
Explore more

More insider trading research around Talis Biomedical Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America